Thanks for reaching out. Be sure to check us out on LinkedIn for all of our current news and announcements.
Oops! Something went wrong while submitting the form.
When BCG studied corporate venturing outcomes, they found that a well-tested venture building approach achieves success 66% of the time. Compare that to the typical innovation failure rate of 72% to 96%, and the gap is staggering. For large companies trying to enter new markets, the method matters as much as the ambition. And increasingly, the evidence points to venture building, executed through corporate venture studios, as the fastest and most reliable path.
Entering a new market has always been one of the hardest things a large company can do. The traditional approaches, acquisitions, joint ventures, internal product development, each carry well-known failure modes. Acquisitions are expensive and integration is brutal. Joint ventures dilute control and move slowly. Internal development gets strangled by the priorities and politics of the core business. Venture building offers a fundamentally different approach: test market entry with startup speed while leveraging the assets that only a corporation can bring to bear.
Large companies are structurally disadvantaged when it comes to entering new markets. Their planning cycles are measured in years. Their capital allocation processes optimize for certainty. Their organizational structures reward execution within known parameters, not exploration of unknown ones.
The irony is that large companies often possess exactly the assets needed to win in adjacent markets: brand recognition, customer trust, distribution infrastructure, regulatory expertise, and proprietary data. The problem is not a lack of resources. It is the inability to deploy those resources with the speed and flexibility that new market entry demands.
This is where the danger of traditional corporate thinking becomes most acute. When executives evaluate a new market opportunity, they default to the same frameworks they use for the core business: total addressable market sizing, five-year financial projections, competitive landscape analysis. But new markets, by definition, resist that kind of certainty. The companies that insist on a fully developed business case before committing resources will always be slower than those willing to invest in learning.
Venture building flips the model. Instead of planning your way into a new market, you experiment your way in. You deploy small, focused teams with clear hypotheses. You validate demand with real customers before committing significant capital. And you use stage-gated investment to scale what works and shut down what does not.
If venture building is the strategy, the corporate venture studio is the vehicle that makes it operational. A venture studio is not an incubator or an accelerator. It is a dedicated unit that systematically identifies, builds, and scales new ventures, typically with its own team, capital, and decision-making authority.
The performance data on studio-backed ventures is compelling. According to research compiled by the Global Startup Studio Network (GSSN), 84% of studio-backed ventures secure seed funding, compared to just 42% for conventional ventures. Studio-originated startups achieve a 53% internal rate of return versus 21% for traditional startups. These are not incremental improvements. They represent a fundamentally different probability of success.
Why do studios outperform? Because they systematize the hardest parts of venture creation: idea validation, team assembly, early customer development, and the transition from experiment to operating business. When a corporation embeds this capability internally or partners with an experienced studio like Highline Beta, it gains a repeatable engine for entering new markets, not just a one-off project.
At Highline Beta, we have seen the evolution toward vertical venture studios as the next maturation of this model, studios that go deep in specific industries and bring sector expertise alongside venture-building methodology. This specialization further accelerates market entry by reducing the learning curve that general-purpose innovation programs face.
Forward 31, the venture studio created by Porsche Digital, demonstrates what lean market entry looks like at a company most people associate exclusively with sports cars. Rather than limiting innovation to automotive technology, Forward 31 has built ventures in mobility services (Navit, an employee mobility platform), hospitality, and other sectors that leverage Porsche's brand equity and technology capabilities without being constrained by the core automotive business. Each venture began as a focused experiment, a small team testing a specific hypothesis in a specific market, before receiving the investment needed to scale.
Alphabet X (formerly Google X) has taken the same principle further. Waymo, Wing, and Verily each represent entry into a distinct market: autonomous transportation, drone delivery, and life sciences, respectively. Alphabet recently launched the $500 million Series X Capital fund to continue backing its venture portfolio. The common thread is that each venture leverages Alphabet's core assets, AI and machine learning, data infrastructure, engineering talent, while operating with enough independence to move at startup speed.
These are not theoretical examples. They are proof points that the world's most valuable companies are using venture building as their primary mechanism for entering new markets.
The corporate examples above are instructive, but the approach is not limited to tech giants and global conglomerates. We have worked with companies across insurance, healthcare, consumer goods, and financial services to use venture building as a market entry strategy.
When Green Shield Canada, one of the country's largest health and dental benefits providers, wanted to explore the mental health market, they faced a challenge familiar to many large companies: the opportunity was clear, but the right approach was not. Through their work with Highline Beta, they were able to validate mental health as a viable new market by testing specific value propositions with real users before committing to a full product build. The venture building approach let them enter a sensitive, complex market with confidence, using their existing healthcare relationships and expertise as an unfair advantage.
Cincinnati Insurance took a similar path when exploring adjacent market opportunities. As a well-established property and casualty insurer, the company had deep expertise and strong agent relationships but needed to find new avenues for growth. Working with Highline Beta, they discovered and validated two new venture opportunities that leveraged their core capabilities in new contexts. The process moved from hypothesis to validated opportunity in a fraction of the time a traditional corporate development process would have required.
In both cases, the stage-gated investment model was critical. Rather than making a large, upfront commitment to a new market, each company invested incrementally: small amounts to validate assumptions, larger amounts as evidence accumulated. This approach fundamentally changes the risk profile of market entry. You are not betting $50 million on a business case built on assumptions. You are investing $500,000 to test those assumptions, and then scaling based on evidence.
One of the most common mistakes in corporate market entry is choosing the wrong market to enter. The temptation is to chase the largest, fastest-growing opportunity. But size and growth rate alone do not determine whether a company has a right to win. Choosing the right vertical requires an honest assessment of what we call the corporate endowment: the specific assets, relationships, data, and capabilities that give a company disproportionate advantage in a particular market.
This concept of corporate endowment leverage is what separates venture building from generic entrepreneurship. A startup entering a new market has to build everything from scratch: brand, distribution, domain expertise, customer trust. A corporation building a venture in an adjacent market starts with many of these already in place. The venture studio's job is to identify which endowments matter most and design ventures that exploit them.
The data supports this focus on leverage. EY-Parthenon found that nearly 45% of companies surveyed have launched a venture with $100 million or more in annual revenue. These are not science experiments. They are material businesses, and they overwhelmingly emerged from markets where the parent company's existing assets created a genuine competitive moat.
Speed matters, but so does rigor. The fastest path to a new market is not the most reckless one. How you kick off a corporate venture building initiative determines whether it generates real market insight or just PowerPoint decks.
The most effective market entry programs share a few characteristics:
At Highline Beta, this structured approach to venture building is what allows our corporate partners to move from market identification to validated venture in months rather than years. The studio model provides the infrastructure, methodology, and experienced operators needed to compress the timeline without cutting corners on validation.
The McKinsey data showing that two-thirds of executives plan to engage in venture building signals something important: this approach is moving from the early adopter phase to the mainstream. Companies that build their market entry capabilities now will have a significant head start over those that wait.
The competitive dynamics are straightforward. In any given adjacent market, there are a limited number of venture opportunities that leverage a corporation's specific endowment. The first company to identify and validate those opportunities captures the advantage. The second company to arrive faces a competitor that has already learned from customers, iterated on the product, and begun to scale.
Traditional market entry methods, M&A, joint ventures, organic product development, will not disappear. But they are increasingly being complemented, and in many cases replaced, by venture building as the primary mechanism for entering new markets. The data on studio-backed venture performance, the growing number of corporate venture studios worldwide, and the executive sentiment surveys all point in the same direction.
The fastest path to a new market is not to buy your way in or to plan your way in. It is to build your way in, with dedicated teams, stage-gated capital, startup methodology, and the full weight of your corporate assets behind you. The companies that understand this are already moving. The question is whether yours will join them.
